Bill118th CongressFiled Mar 29, 2023Health
H.R. 2297
To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, FDA Innovation Account, Cures Act for fiscal year 2024.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Mar 29, 2023)
This bill limits FY2024 funding for the Food and Drug Administration (FDA) Innovation Account, which the FDA uses to implement provisions of the 21st Century Cures Act relating to the development of medical products.
What just happenedApr 7, 2023
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Biggs, Andy [R-AZ-5](R-AZ)Sponsor
5 cosponsors5 R
5cosponsors1committees4actions
- Introduced in HouseMar 29, 2023
- Apr 7, 2023Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 29, 2023IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Mar 29, 2023IntroReferralIntro-H
Introduced in House
- Mar 29, 2023IntroReferral1000
Introduced in House